Results 101 to 107 of about 349 (107)

1969-LB: Effect of Combined Therapy with Once-Weekly Subcutaneous Cagrilintide 2.4 mg and Semaglutide 2.4 mg (CagriSema) on Energy Intake, Gastric Emptying, and Appetite in Adults with Overweight or Obesity

Diabetes
Introduction and Objective: CagriSema is currently under development for chronic weight management and type 2 diabetes. This study characterized the effects of CagriSema on energy intake, appetite, and gastric emptying (GE) in adults with overweight or obesity.
NIKOLAJ BAK, RACHEL GA YEON LEE, ANGELA SINN, SOREN SNITKER, VALDEMAR FUNCH UHRE, EMILY WENANDE, TINE A. BÆKDAL   +6 more
openaire   +1 more source

26-A-9711-ACC CAGRISEMA VERSUS CAGRILINTIDE OR SEMAGLUTIDE MONOTHERAPY AS ANTI-OBESITY MEDICATIONS: A SYSTEMATIC REVIEW AND BAYESIAN NETWORK META-ANALYSIS WITH TRIAL SEQUENTIAL ANALYSIS

Journal of the American College of Cardiology
Bara Hammadeh, Nesreen Alhamwi, Layan Sufian Aldib, Sima Rawal, Naser Mahmoud   +4 more
exaly   +2 more sources

1321-OR: Superior Quality of Weight Loss with a Novel Unimolecular Tetra-Agonist Peptide Targeting GLP-1, GIP, Amylin, and Calcitonin Receptors vs. Tirzepatide and Cagrisema in Diet-Induced Obese Rats

Diabetes
Introduction and Objective: The rising prevalence of obesity and related comorbidities highlights the need for safe, effective, and durable therapies. We evaluated PTT-A, a novel long-acting tetra-agonist targeting GLP-1, GIP, amylin, and calcitonin receptors, in diet-induced obese (DIO) rats and compared its efficacy with tirzepatide and CagriSema.
SOUMITRA S. GHOSH, BEATRIZ HERRERO, M. PILAR VALDECANTOS, PATRICIA RADA, ANGELA M. VALVERDE, CRISTINA RONDINONE   +5 more
openaire   +1 more source

Review for "Efficacy and Safety of Cagrilintide and Cagrisema versus Semaglutide as Anti-Obesity Medications: A Systematic Review, Meta-Analysis and Meta-Regression"

  +5 more sources

26-A-15734-ACC CAGRILINTIDE-SEMAGLUTIDE (CAGRISEMA) VS SEMAGLUTIDE: SUPERIOR WEIGHT LOSS AND COMPARABLE SAFETY THROUGH SYNERGISTIC AMYLIN-GLP-1 CO-THERAPY: A META-ANALYSIS

JACC
Ravi Venkata Sai Krishna Medarametla, Ashok Runkana, Naga Praneeth Vakkalagadda, Choudhary Ahmed Hasan Maqbool, Charitha Karanam Ramapathy, Divya Karanam, edpuganti namratha, Raam Mannam, Ahmed Khalifa, Krishna Kishore Bingi   +9 more
openaire   +1 more source

Author response for "Efficacy and Safety of Cagrilintide and Cagrisema versus Semaglutide as Anti-Obesity Medications: A Systematic Review, Meta-Analysis and Meta-Regression"

null Muhammad Ahmed, null Muhammad Hassan, null Muhammad Tahir, null Muhammad Hussain, null Faisal Islam, null Ghulam Taha Khan, null Muhammad Ahsan, null Shaheer Bin Shafiq, null Ahmed Ibrahim, null Ammad Uddin, null Saad Ahmed Waqas   +10 more
openaire   +1 more source

Decision letter for "Efficacy and Safety of Cagrilintide and Cagrisema versus Semaglutide as Anti-Obesity Medications: A Systematic Review, Meta-Analysis and Meta-Regression"

openaire   +2 more sources